
Pharma and Medical Device IP in Turkey: Patents, Brand Names and Regulatory Timing
How pharma and medtech companies sequence patents, brand-name trademarks and design filings around the regulatory timeline so disclosure never kills novelty.

How pharma and medtech companies sequence patents, brand-name trademarks and design filings around the regulatory timeline so disclosure never kills novelty.

Descriptive brand names feel marketable but leave you with a mark you can barely enforce. Here is the real cost and the secondary-meaning escape route.

A software copyright registration proves authorship and a date, not that your code is original. Here is how it shifts the burden of proof in a code-theft case.

A logo or product shape can be filed as an industrial design, as a trademark, or as both. Here is how the two registers differ and when to choose each one.

Sell your patent outright or license it for royalties? A decision guide to assignment vs licensing: the control and tax trade-offs, plus TURKPATENT recordal.

A Madrid trademark hangs on your Turkish home mark for five years. See how central attack works, what triggers it, and the transformation route that saves you.

Source code is copyright, a technical method may be patentable. Why pure software is hard to patent in Turkey, and the layered strategy a SaaS founder needs.

Copyright never protects an idea, plot, method or format. It protects the specific expression. Here is where that line sits and when a copy crosses it.

A design search does two jobs: it clears your novelty and checks freedom to operate. Where to look across the national, EU, and Hague registers before launch.